T2
Showing 26 - 50 of >10,000
Type 2 Diabetes (T2D) Trial in Maseru, Basel (T2D care package, Referral to the responsible health facility)
Not yet recruiting
- Type 2 Diabetes Mellitus (T2D)
- T2D care package
- Referral to the responsible health facility
-
Maseru, Lesotho
- +1 more
Feb 14, 2023
Diabetes, Type 2 Trial (Peer Coaching - Peer Participants A, Peer Coaching - Peer Participants B, Peer Coaching - Peer
Not yet recruiting
- Diabetes Mellitus, Type 2
- Peer Coaching - Peer Participants A
- +3 more
- (no location specified)
Aug 14, 2023
Type 2 Diabetes Trial in Wauwatosa (DM-CCT, DM-UCT)
Recruiting
- Type 2 Diabetes
- DM-CCT
- DM-UCT
-
Wauwatosa, WisconsinMedical College of Wisconsin
Jan 30, 2023
ESKAPE Pathogens From Whole Blood Using T2MR Bacterial Panel in
Enrolling by invitation
- Vertebral Osteomyelitis
- Infectious Endocarditis
-
Prague, CzechiaBulovka Hospital
Dec 8, 2022
Stereotactic Margins in Localized Bronchial Cancer (T1/T2a, N0)
Recruiting
- Bronchial Cancer
-
Strasbourg, FranceService de chirurgie thoracique - CHU de Strasbourg - France
Oct 28, 2022
Diabetes, Type 2 Trial in Bronx (T2DXcel mobile application)
Completed
- Diabetes Mellitus, Type 2
- T2DXcel mobile application
-
Bronx, New YorkMontefiore Medical Center
Aug 17, 2022
Fibrosis, Liver, Type 2 Diabetes in Obese, Non-Alcoholic Fatty Liver Disease Trial in La Jolla (Semaglutide, Placebo)
Recruiting
- Fibrosis, Liver
- +2 more
- Semaglutide
- Placebo
-
La Jolla, CaliforniaUniversity of California, San Diego
Aug 25, 2023
Dietary Supplement Trial in Tustin (Oligomalt, maltodextrin)
Completed
- Dietary Supplement
- Oligomalt
- maltodextrin
-
Tustin, CaliforniaOrange County Research Center
Jul 26, 2023
Advanced Solid Tumor Trial in Shanghai (B4T2-001 Autologous CAR T cells)
Recruiting
- Advanced Solid Tumor
- B4T2-001 Autologous CAR T cells
-
Shanghai, China/Shanghai, China
- +1 more
Nov 17, 2022
Prostate Cancer Trial in Taiyuan (SpaceOAR Hydrogel)
Recruiting
- Prostate Cancer
- SpaceOAR Hydrogel
-
Taiyuan, Shanxi, ChinaShanxi Cancer Hospital
Feb 9, 2023
T Cell Lymphoma, T-cell Leukemia Trial in Beijing (Efficacy of LCAR-T2C CAR-T cells)
Terminated
- T Cell Lymphoma
- T-cell Leukemia
- Efficacy of LCAR-T2C CAR-T cells
-
Beijing, Beijing, China
- +1 more
Aug 12, 2022
Type 2 Diabetes, Myocardial Fibrosis, Myocardial Inflammation Trial in Seattle (dapagliflozin, Placebo)
Completed
- Type 2 Diabetes Mellitus
- +2 more
- dapagliflozin
- Placebo
-
Seattle, WashingtonUniversity of Washington
Jan 9, 2023
FreeStyle Libre 2 Flash Glucose Monitoring System on
Recruiting
- Diabetes Mellitus
- SMBG Meter
- FreeStyle Libre 2 System
-
Fresno, California
- +4 more
Jan 31, 2023
Type 2 Diabetes Trial (Ultrasound Delivery)
Recruiting
- Type 2 Diabetes
- Ultrasound Delivery
-
New Haven, ConnecticutYale-New Haven Hospital
Nov 10, 2022
Diabete Type 2 Trial in New Haven (Intensification of insulin regimen/Nutrition)
Suspended
- Diabete Type 2
- Intensification of insulin regimen/Nutrition
-
New Haven, ConnecticutYale New Haven Hospital
Jan 13, 2023
Type 2 Diabetes Trial in Hyden (Diabetes Empowerment Education Program)
Recruiting
- Type 2 Diabetes
- Diabetes Empowerment Education Program
-
Hyden, KentuckyUK Center for Excellence in Rural Health, Kentucky Homeplace
Dec 22, 2022
Pressure Injury, Venous Leg Ulcer, Pressure Injury Stage 2 Trial in Calgary, Edmonton (NanoSALV Catalytic)
Recruiting
- Pressure Injury
- +6 more
- NanoSALV Catalytic
-
Calgary, Alberta, Canada
- +3 more
Jan 31, 2023
Diabetes Type 2 Without Complication Trial (Voglibose + Metformin, Glibenclamide + Metformin)
Not yet recruiting
- Diabetes Mellitus Type 2 Without Complication
- Voglibose + Metformin
- Glibenclamide + Metformin
- (no location specified)
Jan 25, 2023
Renal Cell Carcinoma Trial in Sohag (laparoscopic partial nephrectomy)
Not yet recruiting
- Renal Cell Carcinoma
- laparoscopic partial nephrectomy
-
Sohag, EgyptSohag University Hospital
Aug 3, 2022
Type 2 Diabetes, Mild Cognitive Impairment Trial in Nanjing (Henagliflozin, Gliclazide)
Recruiting
- Type 2 Diabetes Mellitus
- Mild Cognitive Impairment
-
Nanjing, Jiangsu, ChinaDivision of Endocrinology, the Affiliated Drum Tower Hospital of
Oct 10, 2023
Analgesia Trial in Cairo (Thermal Radiofrequency, Chemical Neurolysis)
Recruiting
- Analgesia
- Thermal Radiofrequency
- Chemical Neurolysis
-
Cairo, EgyptWalaa Y Elsabeeny
Apr 4, 2022
Diabetes, Type 2 Trial in San Pedro Garza Garcia, Santa Catarina (Integrative Group Program, Conventional treatment for T2DM)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Integrative Group Program
- Conventional treatment for T2DM
-
San Pedro Garza Garcia, Nuevo León, Mexico
- +1 more
May 25, 2023
Cancer T1-N0 or T2-N0 of the Oral Cavity Trial in Montpellier (outpatient surgery for T1-N0 or T2-N0 cancers of the oral cavity
Recruiting
- Cancer T1-N0 or T2-N0 of the Oral Cavity
- outpatient surgery for T1-N0 or T2-N0 cancers of the oral cavity or oropharynx with lymph node search
-
Montpellier, Hérault, FranceGui de Chauliac Hospital, ENT Department 80 rue Augustin Fliche
Mar 30, 2022
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, T2D Trial in Nantong (control group: lifestyle intervention+ metformin+
Enrolling by invitation
- PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
- T2D
- control group: lifestyle intervention+ metformin+ orlistat (obese patients)+ pioglitazone
- the experimental group: lifestyle intervention+ metformin+ orlistat (obese patients)+ Chiglitazar
-
Nantong, Jiangsu, ChinaGu Yunjuan
Feb 27, 2023
Type 2 Diabetes Trial in Oklahoma City (Diabetes Nutrition Education Classes, Healthy Food Security Resource)
Recruiting
- Type 2 Diabetes
- Diabetes Nutrition Education Classes
- Healthy Food Security Resource
-
Oklahoma City, OklahomaOklahoma City Indian Clinic
Oct 5, 2023